Trials / Conditions / Phase 2 Study
Phase 2 Study
3 registered clinical trials studyying Phase 2 Study — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Phase 2 Study to Assess the Safety and Efficacy of Subcutaneous Blinatumomab in Patients With Measurable Resid NCT07192237 | M.D. Anderson Cancer Center | Phase 2 |
| Recruiting | A Phase II Study Evaluating BMS-986504 in MTAP-deleted Pancreatic Cancer NCT07283705 | M.D. Anderson Cancer Center | Phase 2 |
| Recruiting | Phase 2 Study of BTKi-Rituximab Induction Followed by Glofitamab Consolidation in High Risk Untreated MCL Pati NCT07257055 | M.D. Anderson Cancer Center | Phase 2 |